Please use this identifier to cite or link to this item:
http://ir.swu.ac.th/jspui/handle/123456789/19316| Title: | Pazopanib-Induced Reversible Left Ventricular Systolic Dysfunction |
| Authors: | Roongsangmanoon W. Wattanawinitchai K. Charonpongsuntorn C. Chonmaitree P. Wongsoasup A. Rattanajaruskul N. Angkananard T. |
| Keywords: | bisoprolol furosemide hydralazine isosorbide dinitrate losartan pazopanib protein tyrosine kinase inhibitor sunitinib troponin valsartan aged Article breathing disorder breathing rate cardiotoxicity cardiovascular magnetic resonance case report clinical article computer assisted tomography diastolic dysfunction drug withdrawal dyspnea fatigue heart failure heart left ventricle ejection fraction heart left ventricle function heart ventricle arrhythmia human hypertension left ventricular systolic dysfunction lung metastasis male nuclear magnetic resonance imaging ophthalmoscopy orthopnea oxygen saturation renal cell carcinoma soft tissue sarcoma systolic dysfunction tachycardia transthoracic echocardiography |
| Issue Date: | 2022 |
| Abstract: | Pazopanib is a tyrosine kinase inhibitor used for the treatment of advanced renal cell carcinoma and advanced soft tissue sarcoma. The authors describe a patient with advanced renal cell carcinoma who developed severe hypertension and severe left ventricular systolic dysfunction after starting pazopanib therapy with subsequent recovery of left ventricular ejection fraction upon treatment interruption. © JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND |
| URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123318091&doi=10.35755%2fjmedassocthai.2022.S01.00030&partnerID=40&md5=0dc61225497cf3b9c8c93a9208cc471c http://ir.swu.ac.th/jspui/handle/123456789/19316 |
| ISSN: | 1252208 |
| Appears in Collections: | Scopus 2022 (2 Feb) |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.